Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NSRXNasus Pharma Ltd

NYSE · CIK 0002029039
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeother
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts151

Identity from submissions API

NameNasus Pharma Ltd
CIK0002029039
TickersNSRX
ExchangesNYSE
Entity typeother
CategoryNon-accelerated filer<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN516022712
LEI—
Fiscal year end1231
State of incorporationL3 Israel
Phone972 54-255-3956
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
29 HARAKEVET ST
TEL AVIV - YAFO
L3
6618003
Israel
Mailing address
29 HARAKEVET ST
TEL AVIV - YAFO
L3
6618003
Israel

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

105 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 3 3 0001493152-26-053252 6781
2026-11-16 4 4 0001493152-26-052367 3537
2026-11-16 6-K 6-K 0001493152-26-052046 001-42796 261555636 34 53254
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005053 005-95201 261555115 34 15425
2026-11-13 4 4 0001493152-26-051888 6712
2026-10-19 S-8 S-8 0001493152-26-047602 333-299524 261469667 33 278490 1 1
2026-10-08 6-K 6-K 0001493152-26-046340 001-42796 261450168 34 17361
2026-09-23 3 3 0001493152-26-043796 5982
2026-09-21 4 4 0001493152-26-043559 3589
2026-09-18 424B5 424B5 0001493152-26-043370 333-298693 261391493 33 556636
2026-09-18 6-K 6-K 0001493152-26-043342 001-42796 261390881 34 368528
2026-09-14 6-K 6-K 0001493152-26-042488 001-42796 261375871 34 31436
2026-09-11 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002954 333-298693 261375702 33 1707
2026-09-04 6-K 6-K 0001493152-26-041534 001-42796 261362102 34 291760
2026-09-01 F-3 F-3 0001493152-26-041040 333-298693 261351529 33 632942 1 1
2026-08-20 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002715 333-293950 261301592 33 1720
2026-08-19 6-K 6-K 0001493152-26-039148 001-42796 261293033 34 30735
2026-08-19 POS AM POS AM 0001493152-26-039052 333-293950 261292217 33 790943
2026-08-17 6-K 6-K 0001493152-26-038651 001-42796 261284954 34 4697226 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003431 005-95201 261275837 34 15441
2026-07-31 3 3 0001493152-26-035646 3202
2026-07-29 4 4 0001493152-26-035218 3627
2026-07-28 6-K 6-K 0001493152-26-034938 001-42796 261207622 34 29406088
2026-06-22 4 4 0001493152-26-029484 5068
2026-06-09 6-K 6-K 0001493152-26-027929 001-42796 261076108 34 9419413
2026-05-26 S-8 S-8 0001493152-26-025278 333-296252 261021133 33 275125 1 1
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-225115 005-95201 26981918 34 141553
2026-04-22 4 4 0001493152-26-018607 5067
2026-04-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002073679-26-000045 005-95201 26845696 34 101696
2026-04-01 4 xslF345X06/ownership.xml 0001493152-26-014503 4722
2026-03-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001019 333-293950 26824501 33 1719
2026-03-27 3 3 0001493152-26-013399 6132
2026-03-27 3 3 0001493152-26-013388 4649
2026-03-27 3 3 0001493152-26-013389 5400
2026-03-27 3 3 0001493152-26-013387 4737
2026-03-27 3 3 0001493152-26-013383 6397
2026-03-27 3 3 0001493152-26-013384 8585
2026-03-27 3 3 0001493152-26-013386 4893
2026-03-27 3 3 0001493152-26-013385 4684
2026-03-27 POS AM POS AM 0001493152-26-013287 333-293950 26808684 33 426342
2026-03-25 6-K 6-K 0001493152-26-012663 001-42796 26792429 34 57883
2026-03-25 20-F 20-F 0001493152-26-012559 001-42796 26788652 34 18052651 1 1
2026-03-16 6-K 6-K 0001493152-26-010189 001-42796 26754523 34 32077154
2026-03-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000817 333-293950 26754274 33 1706
2026-03-11 CORRESP filename1.htm 0001493152-26-009621 11006
2026-03-06 6-K 6-K 0001493152-26-009135 001-42796 26730861 34 321555
2026-03-06 UPLOAD filename1.pdf 0000000000-26-002335 333-293950 39917
2026-03-04 6-K 6-K 0001493152-26-008780 001-42796 26718886 34 16747
2026-03-02 F-1 F-1 0001493152-26-008581 333-293950 26709637 33 18238266 1 1
2026-02-25 D xslFormDX01/primary_doc.xml 06b 0001493152-26-008057 021-574660 26679829 33 15337
2026-02-24 6-K 6-K 0001493152-26-007802 001-42796 26667225 34 25121142
2026-02-13 6-K 6-K 0001493152-26-006565 001-42796 26629128 34 43226
2026-02-12 6-K 6-K 0001493152-26-006265 001-42796 26622507 34 764331
2026-01-29 6-K 6-K 0001493152-26-004233 001-42796 26578126 34 241563
2026-01-20 6-K 6-K 0001493152-26-002755 001-42796 26541187 34 20174550
2025-12-29 6-K 6-K 0001493152-25-029210 001-42796 251603157 34 4721854 1 1
2025-12-22 6-K 6-K 0001493152-25-028664 001-42796 251589540 34 46112
2025-11-20 6-K 6-K 0001493152-25-024400 001-42796 251501113 34 48468
2025-11-18 6-K 6-K 0001493152-25-023992 001-42796 251492894 34 38687
2025-11-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-022144 005-95201 251475833 34 20053
2025-11-12 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-021898 005-95201 251472592 34 6093
2025-11-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-25-021552 005-95201 251467271 34 6106
2025-11-03 6-K 6-K 0001493152-25-020540 001-42796 251442164 34 11861992
2025-10-08 6-K 6-K 0001493152-25-017378 001-42796 251381317 34 39981
2025-09-30 6-K 6-K 0001493152-25-016290 001-42796 251360421 34 21128
2025-09-05 6-K 6-K 0001493152-25-012675 001-42796 251295025 34 16206
2025-08-20 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001178913-25-003007 005-95201 251237500 34 6212
2025-08-14 6-K 6-K 0001493152-25-011984 001-42796 251219260 34 44773
2025-08-14 424B4 424B4 0001641172-25-023826 333-288582 251216629 33 7184790
2025-08-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002578 333-288582 251208753 33 1707
2025-08-12 CERT NYSE AMERICAN CERTIFICATION 0001143313-25-000055 001-42796 251207446 34 411601
2025-08-08 CORRESP filename1.htm 0001493152-25-011757 12667
2025-08-08 CORRESP filename1.htm 0001493152-25-011755 13612
2025-08-08 8-A12B 8-A12B 0001493152-25-011753 001-42796 251198595 34 25999
2025-08-07 CORRESP filename1.htm 0001493152-25-011715 20901
2025-08-07 F-1/A F-1/A 0001493152-25-011714 333-288582 251195480 33 7326969
2025-08-06 UPLOAD filename1.pdf 0000000000-25-008259 377-07416 43234
2025-07-30 FWP FWP 0001493152-25-011504 333-288582 251167728 34 42768411
2025-07-28 FWP FWP 0001493152-25-011447 333-288582 251153581 34 42245068
2025-07-28 CORRESP filename1.htm 0001493152-25-011445 14909
2025-07-28 F-1/A F-1/A 0001493152-25-011444 333-288582 251153527 33 7726662 1 1
2025-07-16 UPLOAD filename1.pdf 0000000000-25-007481 377-07416 43357
2025-07-09 F-1 F-1 0001641172-25-018388 333-288582 251113550 33 9294271 1 1
2025-05-21 DRSLTR filename1.htm 0001641172-25-011886 14366
2025-05-21 DRS/A filename1.htm 0001641172-25-011885 377-07416 25972355 33 5445948
2025-05-20 UPLOAD filename1.pdf 0000000000-25-005395 377-07416 42865
2025-05-12 DRSLTR filename1.htm 0001641172-25-009588 17406
2025-05-12 DRS/A filename1.htm 0001641172-25-009584 377-07416 25933062 33 6136776
2025-05-07 UPLOAD filename1.pdf 0000000000-25-004853 377-07416 43746
2025-04-29 DRSLTR filename1.htm 0001641172-25-006695 35459
2025-04-29 DRS/A filename1.htm 0001641172-25-006692 377-07416 25889244 33 4867659
2025-04-22 UPLOAD filename1.pdf 0000000000-25-004261 377-07416 45392
2025-04-16 DRSLTR filename1.htm 0001641172-25-005111 35737
2025-04-16 DRS/A filename1.htm 0001641172-25-005110 377-07416 25843609 33 5358155
2025-03-28 UPLOAD filename1.pdf 0000000000-25-003359 377-07416 46802
2025-03-21 DRSLTR filename1.htm 0001641172-25-000174 20023
2025-03-21 DRS/A filename1.htm 0001641172-25-000173 377-07416 25761636 33 5034093
2025-02-18 UPLOAD filename1.pdf 0000000000-25-001867 377-07416 44310
2025-02-06 DRS/A filename1.htm 0001493152-25-005072 377-07416 25595173 33 5574564
2025-02-05 DRSLTR filename1.htm 0001493152-25-005074 45786
2025-01-28 UPLOAD filename1.pdf 0000000000-25-000891 377-07416 52371
2024-12-31 DRSLTR filename1.htm 0001493152-24-052675 88039
2024-12-31 DRS/A filename1.htm 0001493152-24-052673 377-07416 241592558 33 6093730
2024-09-27 UPLOAD filename1.pdf 0000000000-24-011017 377-07416 61304
2024-08-30 DRS filename1.htm 0001493152-24-034512 377-07416 241268502 33 5190353

Latest XBRL company facts

One latest value per concept from companyfacts (151 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 9.02M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
ffd NetFeeAmt NetFeeAmt USD 55.07 2026-10-19 S-8 2026-10-19 0001493152-26-047602
ffd TtlFeeAmt TtlFeeAmt USD 55.07 2026-10-19 S-8 2026-10-19 0001493152-26-047602
ffd TtlOfferingAmt TtlOfferingAmt USD 633,000 2026-10-19 S-8 2026-10-19 0001493152-26-047602
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-19 S-8 2026-10-19 0001493152-26-047602
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-01 F-3 2026-09-01 0001493152-26-041040
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 806,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 829,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AccountsPayableOtherCurrentAndNoncurrent Accounts Payable, Other USD 529,000 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 553,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 21.29M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 447,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -4.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap Assets Assets USD 5.00M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap AssetsCurrent Assets, Current USD 4.86M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 22.80M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 1.24M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.29M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 1.29M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 980,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations Cash Provided by (Used in) Operating Activities, Discontinued Operations USD -56,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 22.80M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 9.02M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 9.02M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap CommonStockValue Common Stock, Value, Issued USD 20,000 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 24.60M 2023-01-01 2023-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 168,112 2023-07-01 2023-07-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 1.80M 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 1.80M 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 2.00M 2024-08-28 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 3,400 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2023-02-28 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 3.34M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 377,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 2.95M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 15,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 3.34M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 3.05M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent Disposal Group, Including Discontinued Operation, Accounts Payable, Current USD 161,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current USD 35,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense Disposal Group, Including Discontinued Operation, General and Administrative Expense USD 4,000 2024-01-01 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.72 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.72 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.23 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.175 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.018 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD -8,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 233,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 435,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD -636,000 2024-01-01 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 1.80M 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 0 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 2.67M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromContinuingOperations Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent USD -5.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.72 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.72 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -51,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent USD -51,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares -0.01 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares -0.01 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 152,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -182,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -27,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 370,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD -78,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD -78,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap InterestReceivable Interest Receivable USD 67,000 2023-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 147,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 53,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 41,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 53,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 29,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap Liabilities Liabilities USD 2.24M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 5.00M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LiabilitiesCurrent Liabilities, Current USD 2.16M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 483,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 36,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 8.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 8.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -3.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -3.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -4.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -4.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD 5.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD 5.86M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic USD 5.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted USD 5.80M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic USD 51,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted USD 51,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingExpenses Operating Expenses USD 4.90M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -4.90M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseCost Operating Lease, Cost USD 12,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 118,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 45,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 73,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeasePayments Operating Lease, Payments USD 27,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 135,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 14.00M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 20,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherAssetsCurrent Other Assets, Current USD 186,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherExpenses Other Expenses USD 423,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 27,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -4.92M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 228,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PaymentsForFees Payments for Other Fees USD 15,000 2023-03-15 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PaymentsForRent Payments for Rent USD 12,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 230,000 2024-01-01 2024-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 14,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PercentageOfInterestBearingDomesticDepositsToDeposits Percentage of Interest-bearing Domestic Deposits to Deposits pure 0.083 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 515,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 329,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 435,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 10.00M 2025-08-01 2025-08-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 8.48M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromLegalSettlements Proceeds from Legal Settlements USD 92,000 2022-08-01 2022-08-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 700.00M 2025-01-01 2025-06-30 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 60,000 2023-01-01 2023-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 957,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 14,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.24M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap RestrictedCash Restricted Cash USD 54,000 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -18.52M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap Revenues Revenues USD 1.24B 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 145,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap SeveranceCosts1 Severance Costs USD 32,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 447,000 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 10 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.754 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 1.27M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 202,934 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 2.86 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures shares 618,871 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares shares 112,611 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 3.11M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 810,571 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 5.31 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 1.27M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 202,934 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 2.86 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 6.04 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 2.77M 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 3.19M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 8.20M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 168,112 2023-01-01 2023-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.01M 2025-01-01 2025-12-31 2025 FY 20-F 2026-03-25 0001493152-26-012559

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →